Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 8/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.49 |
| ▸ | CMA1 | P23946 | 8/20 | 0.44 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | PEPD | P12955 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7323333 | 0.95 | ITGB3 (0.49) | ITGB3ITGA2BCMA1ACE | |
| SCHEMBL7313646 | 0.84 | ITGB3 (0.58) | ITGB3ITGA2BKLK5ACEPEPD | |
| SCHEMBL7288661 | 0.84 | ITGB3 (0.58) | ITGB3ITGA2BKLK5ACEPEPD | |
| SCHEMBL8352620 | 0.83 | CMA1 (0.51) | CMA1KLK5PEPD | |
| SCHEMBL7316962 | 0.83 | CMA1 (0.51) | CMA1KLK5PEPD | |
| SCHEMBL8168154 | 0.83 | CMA1 (0.51) | CMA1KLK5PEPD | |
| SCHEMBL7316705 | 0.82 | CMA1 (0.50) | ITGB3ITGA2BCMA1KLK5 | |
| SCHEMBL7322601 | 0.81 | ITGB3 (0.57) | ITGB3ITGA2BCMA1KLK5 | |
| SCHEMBL7319906 | 0.81 | CMA1 (0.47) | CMA1 | |
| SCHEMBL7317544 | 0.80 | MALT1 (0.43) | CMA1KLK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4691007-A | HUMAN LEUKOCYTE ELASTASE INHIBITORS | ICI AMERICAS INC. (US) | 1987-09-01 | — | — | US | disclosed |
| US-4596789-A | Pharmaceuticals | ICI AMERICAS INC. (US) | 1986-06-24 | — | — | US | disclosed |
| EP-0124317-A2 | Proline derivatives | ICI AMERICAS INC. (US) | 1984-11-07 | — | — | EP | disclosed |